Skip to main content
Livermore
Livermore
ZHEN

CDKV Holdings LLC

SEC CIK
0002109928
Latest filing
Jul 30, 2026

The latest 13F from CDKV Holdings LLC covers Q2 2026 (filed Jul 30, 2026): 276 long positions worth $128.0M. The top 10 holdings make up 55.9% of the portfolio, and the largest is Schwab U.S. Large-Cap Growth ETF at 17.4%. Livermore has 3 filings on Form 13F from this institution, going back to Q4 2025.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
8
Est. +$12.8M
Added
19
Est. +$335.8K
Reduced
60
Est. −$2.40M
Sold out
7
Est. −$9.74M

Top 5 holdings

Share of this quarter's portfolio value

  1. Schwab U.S. Large-Cap Growth ETF808524300
    17.4%$22.3M
  2. Invesco QQQ Tr04609E107
    9.6%$12.2M
  3. Schwab U.S. Large-Cap Value ETF808524409
    9.1%$11.7M
  4. Vanguard Morningstar Growth ETF922908736
    6.3%$8.09M
  5. Schwab U.S. Mid-Cap ETF808524508
    2.5%$3.18M

Biggest buys

New and added positions, by estimated amount bought

  1. Invesco QQQ Tr04609E107
    +$12.2MNew
  2. Northern LTS FD Tr IV66538H278
    +$327.2KNew
  3. iShares Russell 1000 Growth ETF464287614
    +$168.9KAddedConverted for a 4-for-1 split
  4. EWEdwards Lifesciences Corp
    +$140.2KNewHistory
  5. GOOGAlphabet Inc.
    +$31.8KAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. Invesco QQQ Tr04609E107
    +9.55 pp0.0% → 9.6%
  2. Northern LTS FD Tr IV66538H278
    +0.26 pp0.0% → 0.3%
  3. Schwab U.S. Small-Cap ETF808524607
    +0.22 pp2.0% → 2.2%
  4. Schwab U.S. Large-Cap Value ETF808524409
    +0.16 pp9.0% → 9.1%
  5. iShares Russell 1000 Growth ETF464287614
    +0.15 pp0.5% → 0.7%

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. Invesco QQQ Tr46090E107
    −$9.54MSold out
  2. Global X FDS37954Y889
    −$522.1KReduced
  3. Schwab U.S. Large-Cap Growth ETF808524300
    −$269.6KReduced
  4. iShares Tr464288661
    −$178.5KReduced
  5. EWEdwards Lifesciences Corp
    −$124.1KSold outHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. Invesco QQQ Tr46090E107
    −8.37 pp8.4% → 0.0%
  2. iShares Tr464288661
    −0.48 pp2.9% → 2.4%
  3. Global X FDS37954Y889
    −0.40 pp1.3% → 0.9%
  4. iShares Tr464287440
    −0.31 pp2.4% → 2.1%
  5. J P Morgan Exchange Traded F46654Q575
    −0.14 pp1.0% → 0.9%

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$128.0M
+$14.1M (+12.3%) vs. prior quarter
Positions
276
+1 vs. prior quarter
Top 10 concentration
55.9%
Top 10 as share of value
Turnover
10.0%
Q2 2026, one quarter
Average holding period
2.8 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2025), so positions held before then are understated.

13F filings by quarter

3 quarters, going back to Q4 2025. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $128.0M (Q2 2026)

Q4 2025: $116.8MQ1 2026: $113.9MQ2 2026: $128.0M
Q4 2025Q2 2026
13F filings of CDKV Holdings LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Jul 30, 2026276$128.0MSchwab U.S. Large-Cap Growth ETFInvesco QQQ TrSchwab U.S. Large-Cap Value ETFvs. Q1 2026SEC
Q1 2026May 4, 2026275$113.9MSchwab U.S. Large-Cap Growth ETFSchwab U.S. Large-Cap Value ETFInvesco QQQ Trvs. Q4 2025SEC
Q4 2025Feb 17, 2026277$116.8MSchwab U.S. Large-Cap Growth ETFInvesco QQQ Trust Series ISchwab U.S. Large-Cap Value ETF–SEC